Hot Picks: Small-cap pharma stocks in focus as key drug approvals near [BNN Bloomberg (Canada)]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: BNN Bloomberg
BNN Bloomberg spoke with Terry Smith, director of life sciences research at Emerald Advisers, about three small-cap pharmaceutical companies he believes are positioned to benefit from late-stage trials, new indications and expanding treatment markets. Key Takeaways Expanding approved drugs into new disease indications can meaningfully increase revenue without starting from scratch. Late-stage clinical trial readouts are often the most powerful catalysts for small-cap pharmaceutical stocks. Treatments that improve quality of life, even without curing disease, can see strong patient uptake and compliance. Long drug exclusivity periods increase strategic value and acquisition appeal for larger pharmaceutical companies. Investors may accept higher valuations when multiple regulatory and trial catalysts are visible within a short time frame. Read the full transcript below: ANDREW: Time for Hot Picks, and we are zeroing in on the small-cap pharma sector. Our guest's top pic
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR) [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver FailureBusiness Wire
- United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of DirectorsBusiness Wire
- United Therapeutics Corporation (UTHR): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 10/29/25 - Beat
UTHR
Sec Filings
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- 2/3/26 - Form 144
- UTHR's page on the SEC website